147 related articles for article (PubMed ID: 28545627)
1. Impact of Renal Function on Survival After Cardiac Resynchronization Therapy.
Kpaeyeh JA; Divoky L; Hyer JM; Daly DD; Maran A; Waring A; Gold MR
Am J Cardiol; 2017 Jul; 120(2):262-266. PubMed ID: 28545627
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
Höke U; Khidir MJ; van der Velde ET; Schalij MJ; Bax JJ; Delgado V; Marsan NA
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1740-8. PubMed ID: 26408549
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.
Daly DD; Maran A; Hyer JM; Funke F; Waring A; Cuoco FA; Sturdivant JL; Leman RB; Gold MR
Pacing Clin Electrophysiol; 2016 Aug; 39(8):863-9. PubMed ID: 27197959
[TBL] [Abstract][Full Text] [Related]
4. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.
Singal G; Upadhyay GA; Borgquist R; Friedman DJ; Chatterjee NA; Kandala J; Park MY; Orencole M; Dec GW; Picard MH; Singh JP; Mela T
Pacing Clin Electrophysiol; 2015 Oct; 38(10):1192-200. PubMed ID: 26179289
[TBL] [Abstract][Full Text] [Related]
5. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
[TBL] [Abstract][Full Text] [Related]
6. Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction.
Moreira RI; Cunha PS; Rio P; da Silva MN; Branco LM; Galrinho A; Feliciano J; Soares R; Ferreira RC; Oliveira MM
J Interv Card Electrophysiol; 2018 Apr; 51(3):237-244. PubMed ID: 29460235
[TBL] [Abstract][Full Text] [Related]
7. Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.
Pun PH; Sheng S; Sanders G; DeVore AD; Friedman D; Fonarow GC; Heidenreich PA; Yancy CW; Hernandez AF; Al-Khatib SM
Am J Cardiol; 2017 Mar; 119(6):886-892. PubMed ID: 28160975
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
[TBL] [Abstract][Full Text] [Related]
9. Renal function in heart failure: a disparity between estimating function and predicting mortality risk.
Plischke M; Neuhold S; Kohl M; Heinze G; Sunder-Plassmann G; Pacher R; Hülsmann M
Eur J Heart Fail; 2013 Jul; 15(7):763-70. PubMed ID: 23429976
[TBL] [Abstract][Full Text] [Related]
10. Changes in renal function over time in patients with cardiac resynchronisation therapy.
Schaer BA; Hitz L; Sticherling C; Kühne M; Dickenmann M; Jordaens L; Osswald S; Theuns DA
Swiss Med Wkly; 2013; 143():w13863. PubMed ID: 24163096
[TBL] [Abstract][Full Text] [Related]
11. Renal function and mortality following cardiac resynchronization therapy.
Lin G; Gersh BJ; Greene EL; Redfield MM; Hayes DL; Brady PA
Eur Heart J; 2011 Jan; 32(2):184-90. PubMed ID: 21068051
[TBL] [Abstract][Full Text] [Related]
12. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
[TBL] [Abstract][Full Text] [Related]
13. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
[TBL] [Abstract][Full Text] [Related]
14. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin levels predict clinical outcomes in chronic kidney disease (CKD) patients undergoing cardiac resynchronization therapy.
Uchikawa T; Shimano M; Inden Y; Murohara T
Intern Med; 2014; 53(6):555-61. PubMed ID: 24633024
[TBL] [Abstract][Full Text] [Related]
16. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
17. Response to Cardiac Resynchronization Therapy Across Chronic Kidney Disease Stages.
Ter Maaten JM; Martens P; L'hoyes W; Maass AH; Damman K; Dupont M; Mullens W
J Card Fail; 2019 Oct; 25(10):803-811. PubMed ID: 31323302
[TBL] [Abstract][Full Text] [Related]
18. Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy.
Van Bommel RJ; Mollema SA; Borleffs CJ; Bertini M; Ypenburg C; Marsan NA; Delgado V; Van Der Wall EE; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2011 Feb; 57(5):549-55. PubMed ID: 21272745
[TBL] [Abstract][Full Text] [Related]
19. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
[TBL] [Abstract][Full Text] [Related]
20. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
